MedPath
NMPA Approval

Human Growth Hormone for Injection

国药准字SJ20181003

November 17, 2022

S20181003

Drug Information

注射用重组人生长激素

尤得盼

注射剂

4IU(1.33mg)/瓶,复溶后每瓶1.0ml

生物制品

November 17, 2022

November 16, 2027

Company Information

Applicant Company

LG Chem, Ltd.

151 Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Manufacturing Company

LG Chem, Ltd.

129, Seokam-ro, Iksan-si, Jeollabuk-do, Korea

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用重组人生长激素 - NMPA 批准文号 | MedPath